MENU
ALXO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ALX Oncology Holdings (ALXO) Ownership - Who owns ALX Oncology Holdings?
Profile
Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
72
Web
https://www.alxoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
94.41M
P/E Ratio
N/A
Total Cash
148.57M
Projected Growth
N/A
Total Debt
9.84M
Revenue
N/A
Risk (Beta)
0.20
Dividend Yield
N/A
Total Cash/Share
2.82
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ALXO
Capitalization
94.4M
P/E Ratio
N/A
Risk (Beta)
0.20
Dividend Yield
N/A
Total Cash
149M
Total Cash/Share
2.82
Total Debt
9.84M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
137M
P/B Ratio
0.69
Cash Flow
N/A
Earnings
-2.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
53K
Current Ratio
4.82
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-148.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-74.50
Shares Held By Institutions
227M
Shares Outstanding - Current
52.7M
Total Liabilities
48.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-87.979
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage company, which engages in the research and development of therapies for cancer patients
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
72
Web
https://www.alxoncology.com